DailyIQ
|
Sector:Real EstateAll sectors
Last updated 3 minutes ago

DOC·Healthpeak Properties, Inc.

$.
+. (+.%)
After Hours
High
$22.62
Open
$22.40
Market Cap
15.90B
52W High
$22.35
Low
$22.26
P. Close
$22.51
P/E
71.58
52W Low
$15.70
Fwd P/E
678.35
DailyIQ Est.
$22.63
Technical Score (1D)
95
BUY
News Sentiment
79
BULLISH
Healthpeak Properties (DOC) surged after a significant earnings beat, underscoring its strong financial performance and positioning it as a compelling dividend‑heavy choice for income‑focused portfolios. The earnings beat, coupled with an analyst upgrade that raised the target price, propelled DOC to a new 12‑month high, reinforcing investor confidence in its real‑estate portfolio. Rising U.S. personal healthcare spending—up 5.5% in May 2026—drives demand for senior housing and healthcare real estate, a sector DOC is well‑placed to capture, which supports the recent price rally. The aging U.S. population continues to expand the market for senior housing, providing a long‑term growth backdrop that could sustain DOC’s upside over the next 1–10 trading days. The dividend yield remains attractive, offering a steady income stream that may appeal to investors seeking yield in a rising‑rate environment. As DOC approaches its upcoming earnings release, traders should monitor guidance on rental growth and occupancy rates to gauge whether the company can maintain its momentum. Additionally, watch for any changes in DOC’s debt profile, as higher leverage could temper valuation gains and affect risk‑adjusted returns. The analyst upgrade also signals broader market optimism for healthcare‑real‑estate assets, suggesting that DOC could benefit from a sector‑wide rally if demand continues to rise. Finally, keep an eye on macro‑economic indicators such as interest‑rate movements and healthcare spending trends, as they will influence both DOC’s valuation and the broader REIT sector.
Earnings Summary
Healthpeak Properties, Inc. (DOC) is a U.S. real‑estate investment trust that focuses on healthcare facilities, owning and operating outpatient medical, laboratory, and continuing‑care retirement community properties across a geographically diverse portfolio of 703 assets. The REIT operates through its subsidiary Healthpeak OP and maintains joint‑venture interests that broaden its exposure within the healthcare real‑estate sector. In the most recent two quarters, DOC reported a sharp turnaround: Q3 2025 saw a negative EPS of –$0.1819 against an estimate of $0.06, while Q4 2025 produced a robust EPS of $0.47 versus an estimate of $0.0572, marking a 3‑quarter streak of earnings beats. Revenue rose from $678.5 million in Q2 2025 to $690.3 million in Q3 2025 and then to $719.4 million in Q4 2025, reflecting a year‑over‑year increase of roughly 5.6% from Q4 2024’s $681.1 million and a continued upward trajectory in the fourth‑quarter cycle. Historically, DOC has shown a pattern of revenue growth even when earnings have been volatile; the jump in Q4 2025 EPS from the modest $0.0508 in Q4 2024 to $0.47 underscores a significant earnings acceleration that aligns with the REIT’s focus on high‑barrier lab and outpatient leasing. Recent analyst commentary, including Mizuho Securities’ upgrade to overweight and a $24 target price, highlights confidence in DOC’s operational improvements and dividend policy, while JP Morgan’s neutral rating lift to $21 reflects optimism about the company’s portfolio stability and earnings outlook. Investors should watch for lease renewal data and occupancy trends in the next earnings cycle, as early renewals could cement the current upside; key will be commentary on debt‑management strategy and cash‑flow sustainability, which will influence the REIT’s ability to maintain its dividend payout in a tightening interest‑rate environment.}}

EPS

EstBeatMiss
$-0.28$-0.07$0.14$0.36$0.57Q4'24Q1'25Q2'25Q3'25Q4'25Q2'26
QtrEstActual+/−
Q2'26$0.03 - -
Q4'25$0.06$0.47+721.7%
Q3'25$0.06$-0.18-403.2%
Q2'25$0.06$0.06+12.2%
Q1'25$0.04$0.06+40.7%
Q4'24$0.05$0.05-4.7%

Revenue

EstBeatMiss
$671M$687M$703M$719M$734MQ4'24Q1'25Q2'25Q3'25Q4'25Q2'26
QtrEstActual+/−
Q2'26$727M - -
Q4'25$698M$719M+3.0%
Q3'25 - $690M -
Q2'25 - $679M -
Q1'25 - $687M -
Q4'24 - $681M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

DOC Stock Snapshot

DOC is currently trading at $22.51, giving Healthpeak Properties, Inc. a market cap of 15.90B and a P/E ratio of 71.6. Today's range spans $22.26–$22.62, with shares opening at $22.40 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 79/100.

Over the past year DOC has traded between $15.70 and $22.35 - the current price is +43.4% off the 52-week low and +0.7% from the high. 26 analysts cover the stock with a Hold consensus and a mean 12-month target of $22.18 (range $17.00–$29.00), implying downside of -1.5%.

DOC carries a BUY signal on a 95/100 technical score, trades at $22.51 (near 52-week highs), and has bullish sentiment at 79/100. At 15.90B in Real Estate market cap (P/E: 71.6), the name has scale without the index-anchor inertia of mega-cap peers - which means when the bullish momentum runs, the percentage move can be meaningfully larger. Annual range: $15.70–$22.35.

What makes DOC's BUY setup (95/100) particularly actionable at 15.90B in Real Estate capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $22.51 (near 52-week highs in $15.70–$22.35), with sentiment running bullish at 79/100, the setup rewards conviction-sized positioning more than it does speculative small bets.